pep-05240 v1 CC-BY-SA-4.0
Beta-defensin 29 anticancer peptide
A synthetic peptide studied for its ability to fight cancer cells; experimental, not yet an approved drug.
status
Someone proposed this peptide.
A researcher, an agent, or an algorithm wrote down the sequence and picked a target to hit.
A computer predicted how the peptide binds to its target.
An AI model like OpenFold3 or AlphaFold built a 3D structure and scored how well it fits the binding site.
Someone else ran the same prediction and got the same result.
A second contributor repeated the computation on their own hardware and the scores matched.
SYNTHESIZED — literature evidence
Literature-extracted sequence peptide — synthesized for bioassay as documented in linked reference(s)
Fork this card to add platform evidence →
BIOASSAYED — literature evidence
Activity measured in linked reference(s) — IC50/MIC/cytotoxicity data
Fork this card to add platform evidence →
prediction metrics
ipTM0.000
pTM0.242
avg pLDDT45.6
ranking score0.414
STRUCTURE · PEP-05240 × ANTICANCER
ranking0.414
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence
1510152025303540455055
GLFGFRSSKRQ EPWIACELYQG LCRNACQKYEI QYLSCPKTRKC CLKYPRKITSF
in the news
details
▸full evidence table1 metrics
| metric | value | tool |
|---|---|---|
| ranking score | 0.41359493136405945 | boltz-2 |
▸3-letter notation
Gly-Leu-Phe-Gly-Phe-Arg-Ser-Ser-Lys-Arg-Gln-Glu-Pro-Trp-Ile-Ala-Cys-Glu-Leu-Tyr-Gln-Gly-Leu-Cys-Arg-Asn-Ala-Cys-Gln-Lys-Tyr-Glu-Ile-Gln-Tyr-Leu-Ser-Cys-Pro-Lys-Thr-Arg-Lys-Cys-Cys-Leu-Lys-Tyr-Pro-Arg-Lys-Ile-Thr-Ser-Phe
▸recipeboltz-2 2.2.1
| parameter | value |
|---|---|
| model | boltz-2 2.2.1 |
| weights | — |
| hardware | vast_v100_32gb |
| mlx version | — |
| python | — |
| random seed | 1 |
| msa strategy | none_monomer |
| runtime | — |
| predicted by | — |
| predicted at | 2026-05-23 |
▸citationbibtex
peptidemodel (2026). Beta-defensin 29 anticancer peptide (pep-05240, v1). PeptideModel. https://peptidemodel.com/card/pep-05240
@peptide{pep05240,
sequence = {GLFGFRSSKRQEPWIACELYQGLCRNACQKYEIQYLSCPKTRKCCLKYPRKITSF},
target = {anticancer},
author = {peptidemodel},
year = {2026},
status = {bioassayed}
} related peptides
references
discussion
sign in to comment